Optical coherence tomography markers—like the ellipsoid zone—are reshaping clinical trials in intermediate age-related ...

SALT LAKE CITY — In this video, Christine Curcio, PhD, FARVO, discusses how her research into the role of drusen deposits in age-related macular degeneration may make earlier intervention possible.

Session ID: 2025-06-27:e662b7e2895de98e7f3f801f Player Element ID: V7590c4ac_6462_4680_9cd8_92827970d455_6373571370112 ...

Objective: To investigate the risk of age-related macular degeneration (AMD) in association with optic disc drusen (ODD). Design: Observational, cross-sectional study. Participants: Consecutive ODD ...

Findings could help explain the links between macular degeneration and cardiovascular disease, which both worsen with age.

Macular degeneration (MD) is characterised by the progressive breakdown of the macula, the portion of the retina responsible for sharp, central vision, leading to visual distortion or loss. Age ...

Send comments and news tips to [email protected]. Cite this: Edited by Shrabasti Bhattacharya. Intensive Bevacizumab Boosts Vision in Macular Degeneration - Medscape - June 19, 2025.

Macular degeneration usually refers to the age-related degenerative changes in the retina that can result in loss of central vision. It is caused by abnormal blood vessel growth (a condition ...

Source Reference: Shor R, et al "Glucagon-like peptide-1 receptor agonists and risk of neovascular age-related macular degeneration" JAMA Ophthalmol 2025; DOI: 10.1001/jamaophthalmol.2025.1455.

A study of people with diabetes found the risk of macular degeneration remained low, but was 0.2% in people taking GLP-1s, 0.1% in those who didn't.

Macular degeneration is a disease associated with aging that gradually destroys sharp, central vision. Central vision is needed for seeing objects clearly and for common daily tasks such as ...